Vice President, Global Clinical Operations
Lindy Bancke, PharmD is responsible for clinical operations within Ferring globally. The organization she leads handles the planning, implementation, management, and execution of Ferring clinical trials around the world.
Lindy has more than 20 years of experience in clinical development. Prior to her current role, she was Head of Clinical Development at Rebiotix, Inc. (a Ferring Company) where she led a team focused on harnessing the power of the human microbiome to revolutionize the treatment of challenging diseases. She has held leadership roles at biotech and mid-size pharmaceutical companies, including Proximagen and Upsher-Smith.
Lindy’s experience spans the spectrum of drug development, from first-in-human studies to global Phase 3 programs, Phase 4 studies, pediatrics, as well as products with orphan designation, fast track status, and unique regulatory pathways. She has experience with both new chemical entities and generic product development in various therapeutic areas, including neurology, oncology, hormone replacement therapy, infectious disease, and gastroenterology.
Lindy holds a PharmD from the University of Nebraska Medical Center and a Bachelor of Science degree in biology from the University of Nebraska-Lincoln.